Settlement Reached in Vioxx Lawsuit
The following is being released by the law firms of Herman, Herman & Katz, LLC and Leiff Cabraser Heimann & Bernstein.
Merck Sharp & Dohme Corp. (“Merck”) has agreed to pay up to $23 million to settle a class action lawsuit involving the prescription anti-inflammatory drug Vioxx. The lawsuit claims Merck falsely advertised Vioxx as having greater benefits than less expensive medicines contradicting FDA approved labeling. Merck denies these claims but has agreed to a settlement.
Consumers who paid for all or part of the cost of Vioxx before October 1, 2004 are included in the settlement.
To view Multimedia News Release, go to http://www.multivu.com/players/English/63015-vioxx-settlement/
Merck Sharp & Dohme Corp. (“Merck”) has agreed to pay up to $23 million to settle a class action lawsuit involving the prescription anti-inflammatory drug Vioxx. The lawsuit claims Merck falsely advertised Vioxx as having greater benefits than less expensive medicines contradicting FDA approved labeling. Merck denies these claims but has agreed to a settlement.
Consumers who paid for all or part of the cost of Vioxx before October 1, 2004 are included in the settlement.
To view Multimedia News Release, go to http://www.multivu.com/players/English/63015-vioxx-settlement/